gemcitabine

NDC 25021-235 · Sagent Pharmaceuticals

Generic namegemcitabine hydrochloride

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)GEMCITABINE HYDROCHLORIDE

Strength1 g/25mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

25021-235-50 — 1 VIAL in 1 CARTON (25021-235-50) / 25 mL in 1 VIAL

25021-235-51 — 10 VIAL in 1 CARTON (25021-235-51) / 25 mL in 1 VIAL

J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg Medicare Part B payment limit (ASP + 6%): $2.88

FDA lists these products with the same active ingredient.

0143-9342 — Gemcitabine, 0409-0181 — GEMCITABINE, 0409-0182 — GEMCITABINE, 0409-0183 — GEMCITABINE, 0409-0185 — GEMCITABINE, 0409-0186 — GEMCITABINE, 0409-0187 — GEMCITABINE, 16714-909 — GEMCITABINE HYDROCHLORIDE, 16714-930 — GEMCITABINE HYDROCHLORIDE, 25021-234 — gemcitabine hydrochloride, 25021-239 — gemcitabine, 55111-686 — gemcitabine, 55111-687 — gemcitabine, 63323-102 — GEMCITABINE, 63323-125 — GEMCITABINE, 63323-126 — GEMCITABINE, 67457-616 — GEMCITABINE HYDROCHLORIDE, 67457-617 — GEMCITABINE HYDROCHLORIDE, 67457-618 — GEMCITABINE HYDROCHLORIDE, 68001-342 — GEMCITABINE, +13 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.